title: Adjuvant therapy is valuable in the treatment of rectal cancer despite total mesorectal excision.
authors.forename: Patrick
authors.initials: P
authors.lastname: Colquhoun
authors.forename: Steven D
authors.initials: SD
authors.lastname: Wexner
authors.forename: Alfred
authors.initials: A
authors.lastname: Cohen
mesh_terms: D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local / Q000209:etiology / Q000628:therapy; D009367:Neoplasm Staging; D011183:Postoperative Complications; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic; D012004:Rectal Neoplasms / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*; D012007:Rectum / Q000601:surgery*